Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
351
datasets available to search
ShareScore release 0.9.0
Dataset results
351 results for “empagliflozin”
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
ClinicalTrials.gov study NCT02182830. IPD Sharing: Not stated. Countries: 1. Publications: 3.
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Sympt
ClinicalTrials.gov study NCT03448419. IPD Sharing: Not stated. Countries: 11. Publications: 3.
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
ClinicalTrials.gov study NCT04509674. IPD Sharing: YES. Countries: 22. Publications: 3.
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Sym
ClinicalTrials.gov study NCT03448406. IPD Sharing: Not stated. Countries: 11. Publications: 3.
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy
ClinicalTrials.gov study NCT01649297. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Empagliflozin in Chinese Female and Male Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01316341. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
ClinicalTrials.gov study NCT01969747. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01947855. IPD Sharing: Not stated. Countries: 1. Publications: 3.
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
ClinicalTrials.gov study NCT03594110. IPD Sharing: YES. Countries: 8. Publications: 15.
Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02121483. IPD Sharing: Not stated. Countries: 5. Publications: 2.
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).
ClinicalTrials.gov study NCT01131676. IPD Sharing: Not stated. Countries: 42. Publications: 39.
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
ClinicalTrials.gov study NCT03057951. IPD Sharing: Not stated. Countries: 23. Publications: 20.
Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01719003. IPD Sharing: Not stated. Countries: 21. Publications: 1.
Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01368081. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Relative Bioavailability of Empagliflozin (BI 10773) and Ramipril Administered Together Compared to Empagliflozin (BI 10773) and Ramipril Alone in Healthy Volunteers
ClinicalTrials.gov study NCT01284621. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension
ClinicalTrials.gov study NCT00881530. IPD Sharing: Not stated. Countries: 21. Publications: 1.
A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes
ClinicalTrials.gov study NCT03993132. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure
ClinicalTrials.gov study NCT04157751. IPD Sharing: YES. Countries: 15. Publications: 4.
Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food
ClinicalTrials.gov study NCT01189201. IPD Sharing: Not stated. Countries: 1. Publications: 1.
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
ClinicalTrials.gov study NCT03057977. IPD Sharing: Not stated. Countries: 20. Publications: 29.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.